NEW YORK, Sept. 16-Cellzome has hired Roche discovery chief David Brown as president and chief executive officer, the company said today.
Brown will help guide the company as it progresses into drug development, former CEO Charles Cohen said in a statement.
He was previously global head of discovery at Roche, where he oversaw drug candidate development, in-licensing and acquisitions. Previously, at Pfizer, Brown was involved in developing Viagra.
Cohen will now chair Cellzome's supervisory board.
Cellzome's core research is in functional proteomics. The company plans to move into drug development by creating treatments for neurological disease, cancer, metabolic disorders and inflammation-related disease. It is based in Heidelberg, Germany.